Investors

Alterola Biotech aims to bring next generation cannabinoid and cannabinoid-like pharmaceutical medicines to the market in the form of life changing medicines.

Alterola Biotech is quoted on the OTC market (OTC: ABTI), if you are interested in receiving more detailed information about our financial projections and investment opportunities, please contact us using the form below or email our investor relations team at ir@alterolabio.com.

unnamed (1)

FINANCIAL OUTLOOK

DAVID HITCHCOCK (OBE)
Chief Executive Officer

“We’re excited for our future patients and investors! Alterola Biotech aims to bring next generation cannabinoid and cannabinoid-like pharmaceutical medicines to the market in the form of life changing medicines.

Our diversified portfolio of product candidates and technologies will potentially allow us to generate multiple revenue streams, which should significantly impact top-line growth and generate upside pressure to our stock price.”